News | Prostate Cancer | November 01, 2023

Reimbursement code improves access to personalized prostate cancer care with Avenda Health’s AI cancer mapping platform, Unfold AI 

Reimbursement code improves access to personalized prostate cancer care with Avenda Health’s AI cancer mapping platform, Unfold AI

November 1, 2023 — The American Medical Association (AMA) has announced its 2024 Current Procedural Terminology (CPT) code set will include a new Category III code for Avenda Health’s innovative Unfold AI™, a cancer AI platform that creates new clinically meaningful insights to aid physicians and patients in making informed treatment decisions. CPT codes are used to report medical procedures and services for processing claims, conducting research, evaluating utilization and developing medical guidelines. The Category III designation is a temporary code for new and developing technologies. 

The comprehensive description of the new code is: 

X237T- Non-invasive prostate cancer estimation map, derived from augmentative analysis of image-guided fusion biopsy and pathology, including visualization of margin volume and location, with margin determination and physician interpretation and report.  

“This recognition by the CPT Editorial Panel is a testament to our dedication to providing cutting-edge solutions in the field of cancer diagnosis and treatment,” said Dr. Brittany Berry-Pusey, COO and co-founder. “The new CPT code solidifies our position as a frontrunner in revolutionizing cancer care and our commitment to making our technology accessible to all patients.” 

Unfold AI is a decision support platform that provides the physician and the patient with critical information, comprehensive insights, and planning guidance to ensure the patient is put on the right path for their unique cancer journey. By integrating patient-specific data from prostate imaging and biopsies the platform generates a customized cancer probability map using state-of-the-art machine learning. Its 3D, AI-generated map enables physicians to visualize the precise location of cancer for informed intervention planning.  

Avenda Health recently announced Unfold AI’s use by Matthew Allaway, D.O. at Urology Associates in Maryland, leveraging the FDA-cleared technology in their procedures. Avenda plans to expand to major teaching hospitals and urology practices nationwide, ensuring widespread access to advanced cancer care solutions.  

The full set of Category III codes are published annually in the CPT codebook. The most recently approved codes will be posted to the AMA CPT website January 1, 2024 with an effective implementation date of July 1, 2024. 

For more information: avendahealth.com 


Related Content

Feature | Information Technology | By Melinda Taschetta-Millane

The Healthcare Information and Management Systems Society (HIMSS) Global Health Conference and Exhibition brought ...

Time May 01, 2024
arrow
News | Breast Imaging

April 30, 2024 — Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports ...

Time April 30, 2024
arrow
Feature | Information Technology | By Jef Williams

The rapid growth of healthcare data has reached unprecedented heights, making up about 30% of the world’s stored data.¹ ...

Time April 30, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
Feature | Breast Imaging | By Christine Book

From implementing artificial intelligence effectively, advocating for radiologists, and working tirelessly to expand ...

Time April 29, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Information Technology

April 25, 2024 — NewVue Inc., a leader in innovative cloud-native radiology workflow solutions, announced a strategic ...

Time April 25, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Ultrasound Imaging

April 22, 2024 — GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which ...

Time April 22, 2024
arrow
News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
Subscribe Now